The IRE website will undergo maintnenance on Friday, February 3.
Cart 0 $0.00
IRE favicon

Shop

Resource ID: #5601
Subject: Health Care
Source: Barron's
Affiliation: 
Date: 

$0.00

Description

Barron's looks at Genentech's new drug for heart-attack victims, TPA; the drug was promoted as the miracle medicine that could dissolve blood clots, but the FDA may have approved it too quickly; finds side effects include fatal reactions such as cerebral hemorrhaging, Jan. 11 and Nov. 21, 1988.

109 Lee Hills Hall, Missouri School of Journalism   |   221 S. Eighth St., Columbia, MO 65201   |   573-882-2042   |   info@ire.org   |   Privacy Policy
apartmentpenciluserscalendar-fullcrossmenu linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram
My cart
Your cart is empty.

Looks like you haven't made a choice yet.